Episode 19 - Rigosertib in RDEB cutaneous SCC
Update: 2025-09-17
Description
In this episode of BJD Talks, Sam and Meera discuss the article ‘Efficacy and safety of rigosertib in patients with recessive dystrophic epidermolysis bullosa-associated advanced/metastatic cutaneous squamous cell carcinoma’ by Laimer et al. The full article can be accessed at https://doi.org/10.1093/bjd/ljaf205
*This podcast was generated by an AI tool created by 67Bricks for the British Association of Dermatologists*
*This podcast was generated by an AI tool created by 67Bricks for the British Association of Dermatologists*
Comments
In Channel
Download from Google Play
Download from App Store
United States00:00
00:00
1.0x
